Other stimulant related disorders
Chapter 5:Mental, Behavioral and Neurodevelopmental disorders
ICD-10 F15 is a billable code used to indicate a diagnosis of other stimulant related disorders.
F15 encompasses a range of stimulant-related disorders that arise from the use of substances such as amphetamines, cocaine, and other stimulants not classified elsewhere. These disorders can manifest as stimulant use disorder, characterized by a problematic pattern of stimulant use leading to significant impairment or distress. Symptoms may include cravings, tolerance, withdrawal, and continued use despite negative consequences. Withdrawal symptoms can include fatigue, depression, and increased appetite, while intoxication may lead to heightened energy, euphoria, and increased sociability. Treatment often involves behavioral therapies, counseling, and support groups, with some cases requiring pharmacological interventions to manage withdrawal symptoms or co-occurring mental health disorders. Accurate diagnosis and coding are crucial for effective treatment planning and insurance reimbursement, as stimulant-related disorders can significantly impact an individual's health and social functioning.
Detailed patient history, including substance use patterns and treatment history.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring long-term management.
Documentation must clearly outline the severity of the disorder and any co-occurring mental health conditions.
Comprehensive mental health evaluations and treatment plans.
Patients with stimulant use disorder presenting with anxiety, depression, or psychosis.
Accurate assessment of the impact of stimulant use on mental health is essential for proper coding.
Used when assessing a patient for stimulant use disorder.
Comprehensive assessment notes and treatment recommendations.
Addiction specialists should document substance use history in detail.
F15 includes disorders related to the use of various stimulants such as amphetamines, cocaine, and other non-specified stimulants that lead to significant impairment or distress.
Stimulant intoxication typically presents with symptoms such as increased energy, euphoria, and decreased appetite, while withdrawal may involve fatigue, depression, and increased appetite. Accurate documentation of the patient's history and symptoms is essential.
